1091208-89-7

Upstream product

• 1036343-08-4 2-p-methyloxyphenyl-4-(2-phenyl-1,2,3-triazol-4-yl)-2,3-dihydro[1,5]benzothiazepine 
• 38435-51-7 N-hydroxy-4-methoxy-benzenecarboximidoyl chloride 

Relevant academic research and scientific papers

Synthesis and crystal structure of compound 1,5-bis(4-methoxyphenyl)-3a-(2- phenyl-2H-1,2,3-triazol-4-yl)-4,5-dihydro-3aH-benzo[b][1,2,4]oxadiazolo[4,5-d] [1,4]thiazepine

The crystal structure of title compound has been determined. The compound crystallizes in the triclinic system with space group P-1, lattice parameters; a = 9.2938 (5) A, b = 11.9992 (7) A, c = 25.5918 (13) A, α = 91.343 (2)°, β = 95.8360 (10)°, γ = 101.005 (2)°, V = 2784.3 (3) A3, Z = 4, X-Ray analysis reveals that the molecular backbone consists of tricyclic system with the central seven-membered ring in twisted chair-like conformation. The crystal structure of 1,5-bis(4-methoxyphenyl)-3a-(2-phenyl-2H-1,2,3-triazol-4-yl)-4,5-dihydro-3aH- benzo[b][1,2,4]oxadiazolo[4,5-d][1,4]thiazepine was first determined by single-crystal X-ray diffraction which reveals that the molecular backbone consists of a tricyclic system with the central seven-membered ring in twisted chair-like conformation.